BTG receives CE mark certification for radiopaque drug-eluting bead
6 April 2017 | By Niamh Marriott, Junior Editor
BTG has received Class III CE Mark certification for DC Bead LUMI, the first commercially available radiopaque drug-eluting bead...
List view / Grid view
News
New drug reduces daily menopausal hot flushes by 73%
6 April 2017 | By Niamh Marriott, Junior Editor
In a trial carried out at Imperial College, researchers showed that women who suffered seven or more hot flushes a day could reduce the number by 73%...
FDA grants Kitov waiver for new drug application filing fee
6 April 2017 | By Niamh Marriott, Junior Editor
The US Food and Drug Administration (FDA) has granted Kitov Pharmaceuticals a waiver related to the $2,038,100 new drug application filing fee for KIT-302...
Novartis’ lung cancer drug combination receives EU approval
5 April 2017 | By Niamh Marriott, Junior Editor
The European Commission has approved Novartis’ Tafinlar (dabrafenib) in combination with Mekinist (trametinib) to treat fnon-small cell lung cancer...
New report reveals little progress on 2014 WHO psoriasis recommendations
5 April 2017 | By Niamh Marriott, Junior Editor
A new report by the Economist Intelligence Unit (EIU) reveals governments have taken little or no action to improve care for those living with psoriasis...
Phase II Lymphoma study of Daratumumab will not continue to stage 2
4 April 2017 | By Niamh Marriott, Junior Editor
Janssen Biotech has decided not to initiate stage 2 of the Phase II study of daratumumab in three types of relapsed or refractory non-Hodgkin’s lymphoma...
AstraZeneca lung cancer drug receives FDA approval
4 April 2017 | By Niamh Marriott, Junior Editor
The US Food and Drug Administration (FDA) has granted full approval for AstraZeneca’s Tagrisso (osimertinib) tablets, for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, whose disease has progressed on or after an EGFR…
IntelliCyt launches novel assay system to accelerate cell line development
3 April 2017 | By IntelliCyt
The IntelliCyt Cy-Clone™ PLUS Assay System will accelerate and improve the quality of clone ranking and selection for developing cell lines which can reduce production costs of biopharmaceuticals...
FDA approves Sanofi and Regeneron’s new eczema drug
The US Food and Drug Administration (FDA) approved Sanofi and Regeneron's Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis).
NICE does not recommend Shire’s pancreatic cancer drug
3 April 2017 | By Niamh Marriott, Junior Editor
The National Institute or Health and Care Excellence (NICE) has published final guidance that does not recommend pegylated liposomal irinotecan (Onivyde, Shire).
Cherwell makes an impact – with new continuous monitoring microbial air samplers
31 March 2017 | By Cherwell Laboratories
ImpactAir® high performance air sampler range joins Cherwell’s portfolio of cleanroom microbiology products...
First female CEO of GSK to be paid 25% less than her male predecessor
31 March 2017 | By Niamh Marriott, Junior Editor
Emma Walmsley will succeed Andrew Witty as GSK CEO, when he retires on 31 March 2017, making her the first female CEO of a major global pharmaceuticals company.
AstraZeneca’s potential drug for neuromyelitis optica spectrum disorder receives EU orphan designation
30 March 2017 | By Niamh Marriott, Junior Editor
AstraZeneca and its global biologics research and development arm, MedImmune, announced that the European Medicines Agency (EMA) has granted orphan designation to inebilizumab (formerly MEDI-551) for the treatment of neuromyelitis optica spectrum disorder (NMOSD).
Precision NanoSystems NanoAssemblr™ chosen for Horizon 2020 project to develop novel RNA therapeutics
29 March 2017 | By Precision NanoSystems
Precision NanoSystems NanoAssemblr™ platform has been selected for the controlled manufacture of nanomedicines as part of the multinational B-SMART (Brain-Specific, Modular and Active RNA Therapeutics) translational research project...
Rainin’s pipette service puts the customer first
29 March 2017 | By Mettler Toledo
Careful maintenance of precision pipettes is essential in the highly regulated pharmaceutical and clinical diagnostics industries...
